DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a23fa3/healthcare_overvie) has announced the addition of Frost & Sullivan's new report "Healthcare Overview of Mozambique" to their offering.
Healthcare Overview in Mozambique provides an overview of the healthcare industry, and pharmaceuticals, in Mozambique. The research service analyses Mozambique's healthcare environment in great depth, focusing on health structure, infrastructure and human resources, financing, procurement and the regulatory system. The core of the research is a thorough analysis of the pharmaceutical industry, specifically examining generic and branded drug market segments. For each of these segments, market sizes and growth forecasts were determined from 2009 to 2016. The research service identifies the key growth opportunities available in the Mozambican pharmaceutical market
Research Overview This Frost & Sullivan research service titled Healthcare Overview of Mozambique provides a strategic analysis of the healthcare structure, identifies challenges, drivers and restraints and provides revenue forecasts from 2009 to 2016. Furthermore, strategic recommendations are provided. In this research, Frost & Sullivan's expert analysts thoroughly examine the following segments: branded and generic drugs.
Market Overview
Healthcare Overview of Mozambique - Affordable Generics to Spur Development of the Mozambiques Pharmaceutical Market
Until recently, the pharmaceutical market in Mozambique had been inactive and largely donor-driven. However, in the last few years, it has experienced faster growth rates due to the large influx of affordable generic drugs. For a country that had grappled with drug shortages for too long, the surge in availability of low-cost generics has considerably improved access to medicines. Government health policy has been a key driver of this development. As part of wide-ranging reforms, the government instituted new drug registration measures aimed at curbing illegal imports, while at the same time promoting importation of legitimate generic products.
The pharmaceutical market in Mozambique will be driven by the increased availability of affordable generic drugs, notes the analyst of this research. The rising incidences of infectious diseases in the country paralleled by economic growth and higher incomes will drive spending, boosting market prospects. Greater availability of affordable drugs drives the uptake of medication. The supply of generic drugs has expanded since the government revamped the regulatory environment and improved enforcement mechanisms to eliminate counterfeit products. Additionally, new regulations have made it mandatory for doctors in the public sector to prescribe generic drugs wherever possible.
Companies Should Leverage Informal Distribution Networks to Maximise on Opportunities in the Rural Market
Currently, one of the most significant challenges in Mozambique is the lack of adequate distribution networks. This affects drug supply and contributes to shortages of essential medication. Outside of Maputo, distribution networks and storage facilities are insufficient, explains the analyst. It is, therefore, a challenge to move commercial goods to other parts of the country, mainly the central and northern provinces. The result of this is that citizens in remote regions lack access to essential medicines that are otherwise available in the country.
The rural market presents vast opportunities, and it has not been properly exploited to its full potential. Distribution networks in remote areas are, however, inefficient, and companies can utilise the informal sector, which currently represent the most effective way to penetrate these markets. Companies need to leverage the informal network in order to penetrate the rural market, advises the analyst. This approach suits over-the-counter (OTC) products whose uptake has not been curtailed by the countrys shortage of qualified healthcare workers.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market segments in this research:
- Branded drugs
- Generic drugs
Key Topics Covered:
1. Executive Summary
2. Research Aim and Objectives
3. Research Scope, Definitions and Exchange Rates
4. Research Methodology
5. Mozambique Country Overview
6. Healthcare Industry Overview
7. Pharmaceutical Industry
8. Pricing Analysis
9. Opportunity Analysis
10. Strategic Recommendations
For more information visit http://www.researchandmarkets.com/research/a23fa3/healthcare_overvie